A retrospective study of the relation between vaccination and occurrence of seizures in Dravet syndrome

Related Experiment Video

Updated: Jun 5, 2026

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy
06:58

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy

Published on: July 12, 2021

Blanca Tro-Baumann1, Sarah von Spiczak, Jan Lotte

  • 1Department of Neuropediatrics, BHZ Vogtareuth, Epilepsy Center, Vogtareuth, Germany.

Epilepsia
|January 12, 2011
PubMed

Insights

Seizures following vaccinations are common in Dravet syndrome, a severe epilepsy. Many children experienced their first seizure after vaccination, often linked to fever, highlighting the need for preventative measures.

Area of Science:

  • Epilepsy Research
  • Genetics
  • Pediatric Neurology

Background:

  • Dravet syndrome is a severe early-life epileptic encephalopathy.
  • SCN1A gene mutations are found in most Dravet syndrome patients.
  • Fever-induced seizures are a hallmark, and vaccination reactions are suspected but not well-studied.

Purpose of the Study:

  • To systematically assess the occurrence and characteristics of seizures following vaccinations in children with Dravet syndrome.
  • To investigate the association between vaccination, fever, and seizure provocation in this population.

Main Methods:

  • Retrospective evaluation of 70 patients diagnosed with Dravet syndrome and SCN1A mutations.
  • Analysis of reported seizure events occurring after vaccinations.

Main Results:

  • Seizures following vaccination were reported in 27% of patients.
  • For 58% of these, vaccination-related seizures were the initial clinical presentation.
  • Most seizures occurred within 72 hours of DPT vaccination, often associated with fever (two-thirds of cases).

Conclusions:

  • Vaccination-triggered seizures are a significant and common feature in Dravet syndrome.
  • Preventive strategies for vaccination or fever-induced seizures are crucial for these children.

More Related Videos

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy09:57

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

Published on: September 20, 2024

Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury09:16

Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury

Published on: June 21, 2019

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Seizures ll: Types01:19

Seizures ll: Types

Seizures are sudden bursts of abnormal electrical discharge in the brain that interfere with normal function. They are commonly divided into three groups: focal seizures, generalized seizures, and other types that do not fit neatly into either category.Focal SeizuresFocal seizures begin in a single brain region. When awareness is preserved, they are called focal aware seizures and may cause sensations such as tingling, unusual smells, or flashing lights. When awareness is impaired, they are...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.